CapEx News
Project News,Updates,Bids & Tenders for Consultants,EPC Contactors,Industrial Suppliers & Service Providers
Uttar Pradesh government is set to invest approximately Rs 8,000 crore in a proposed bulk drug park situated in Lalitpur district, covering an extensive 1,472 acres across five villages in the Bundelkhand region.
Managed by the UP State Industrial Development Authority (UPSIDA), the Lalitpur bulk drug park is a strategic initiative to establish Uttar Pradesh as a prominent hub for pharmaceuticals, generic medicines, and medical devices in South Asia.
The project involves the immediate development of 300 acres of land, with the state government having already inked 236 memoranda of understanding (MoUs) worth Rs 11,000 crore with various companies and consortiums for the establishment of manufacturing plants.
Mayur Maheshwari, CEO of UPSIDA, highlighted the significance of the pharma park project in driving industrial growth and economic development in Uttar Pradesh. He emphasized that it would play a crucial role in contributing to the pharmaceutical sector, creating economic opportunities, and solidifying the state's position on the industrial landscape.
Under the new UP Pharma Policy 2023, the Lalitpur bulk drug park will focus on bulk drugs, starting/raw materials, and active pharmaceuticals. Adani Gas has been engaged to supply piped natural gas (PNG) to the park.
Recent News
◉ SWELECT Energy secures over 150 MW of solar module - Mar 13,2025◉ RVNL emerges as lowest bidder for Rs 554.64 crore road contract - Mar 13,2025
◉ MoU inked for developing Multi-Modal Logistics Park in Varanasi - Mar 13,2025
◉ Danfoss India to invest Rs 1,200 crore by 2028 - Mar 13,2025
◉ SJVN to develop Rs 9,500 crore pumped storage project - Mar 13,2025
◉ JNPA signs concession agreement for Rs 285-crore agri-processing facility - Mar 13,2025
◉ Montra Electric opens e-SCV manufacturing plant in Chennai - Mar 13,2025